Register

Dexcom Real-Time CGM Interoperability – The Foundation for Patient Choice & Success in Diabetes Management

A Dexcom presentation held in conjunction with the 57th EASD Annual Meeting.

Monday, September 27, 2021
12:30 – 13:30 CEST / 6:30 – 7:30 AM EDT

Jake Leach
Chief Technology Officer, Dexcom

Pratik Choudhary
Professor of Diabetes, Leicester University Leicester Diabetes Centre

Geraldine Gallen
Type 1 Diabetes Lead, Senior Diabetes Specialist Nurse, Kings College Hospital NHS Foundation Trust

BRIEF SAFETY STATEMENT

Failure to use the Dexcom G6 Continuous Glucose Monitoring System (G6) and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the G6 do not match symptoms or expectations or you’re taking over the recommended maximum dosage amount of 1000mg of acetaminophen every 6 hours, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.